Henry Schein (NASDAQ:HSIC) PT Lowered to $72.00

Henry Schein (NASDAQ:HSIC) had its price objective reduced by UBS Group from $75.00 to $72.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price target would indicate a potential upside of 6.95% from the stock’s previous close.

A number of other brokerages have also issued reports on HSIC. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday. Piper Sandler reissued an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. Finally, Evercore ISI dropped their price target on Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $79.17.

Henry Schein Price Performance

Shares of Henry Schein stock traded up $3.40 during trading on Wednesday, hitting $67.32. The stock had a trading volume of 1,479,592 shares, compared to its average volume of 1,202,627. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The firm has a market cap of $8.62 billion, a P/E ratio of 22.67, a PEG ratio of 1.80 and a beta of 0.87. The business has a fifty day moving average of $67.84 and a two-hundred day moving average of $71.68. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company’s revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 earnings per share. On average, sell-side analysts expect that Henry Schein will post 5.16 earnings per share for the current fiscal year.

Institutional Trading of Henry Schein

Large investors have recently made changes to their positions in the stock. Summit Securities Group LLC bought a new stake in shares of Henry Schein during the 2nd quarter worth about $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein in the 2nd quarter valued at approximately $37,000. Blue Trust Inc. raised its holdings in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Mather Group LLC. raised its holdings in Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after acquiring an additional 216 shares in the last quarter. Finally, Palisade Asset Management LLC acquired a new position in Henry Schein in the 1st quarter valued at approximately $113,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.